SEYA, T., TAKEDA, Y., TAKASHIMA, K., YOSHIDA, S., AZUMA, M., & MATSUMOTO, M. (2018). Adjuvant immunotherapy for cancer: Both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy. Proc Jpn Acad Ser B Phys Biol Sci.
Čikaški stil citiranjaSEYA, Tsukasa, Yohei TAKEDA, Ken TAKASHIMA, Sumito YOSHIDA, Masahiro AZUMA, i Misako MATSUMOTO. "Adjuvant Immunotherapy for Cancer: Both Dendritic Cell-priming and Check-point Inhibitor Blockade Are Required for Immunotherapy." Proc Jpn Acad Ser B Phys Biol Sci 2018.
MLA način citiranjaSEYA, Tsukasa, et al. "Adjuvant Immunotherapy for Cancer: Both Dendritic Cell-priming and Check-point Inhibitor Blockade Are Required for Immunotherapy." Proc Jpn Acad Ser B Phys Biol Sci 2018.